We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
Cap. Flow
-$786M
Cap. Flow %
-52.7%
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Consumer Discretionary 3.94%
3 Healthcare 3.91%
4 Communication Services 2.7%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWI icon
676
PUT
iShares MSCI Italy ETF
EWI
$1.08B
$71K ﹤0.01%
+3,400
New +$90.8K
LULU icon
677
lululemon athletica
LULU
$14.3B
$71K ﹤0.01%
372
-788
-68% -$176K
ORIO
678
Orion Digital Corp
ORIO
$18.7M
$71K ﹤0.01%
20,978
-2,532
-11% -$16.7K
FIT
679
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
$71K ﹤0.01%
10,600
+3,600
+51% +$23.3K
FG
680
DELISTED
FGL Holdings Ordinary Shares
FG
$71K ﹤0.01%
+7,200
New +$76.1K
IMAX icon
681
PUT
IMAX
IMAX
$2.81B
$70K ﹤0.01%
+7,700
New +$122K
AAOI icon
682
Applied Optoelectronics
AAOI
$11.2B
$69K ﹤0.01%
9,141
-2,558
-22% -$27K
SNAP icon
683
CALL
Snap
SNAP
$9.2B
$69K ﹤0.01%
5,800
-13,800
-70% -$212K
EVBG
684
DELISTED
Everbridge, Inc. Common Stock
EVBG
$69K ﹤0.01%
+653
New +$64.1K
META icon
685
PUT
Meta Platforms (Facebook)
META
$1.54T
$67K ﹤0.01%
400
-6,300
-94% -$1.23M
OVV icon
686
Ovintiv
OVV
$17.6B
$67K ﹤0.01%
24,814
+1,918
+8% +$25.2K
REGN icon
687
Regeneron Pharmaceuticals
REGN
$83B
$67K ﹤0.01%
138
-2,229
-94% -$919K
VNDA icon
688
Vanda Pharmaceuticals
VNDA
$294M
$67K ﹤0.01%
6,502
+2,409
+59% +$29.9K
FITB
689
Fifth Third Bancorp
FITB
$52.3B
$66K ﹤0.01%
4,468
-7,059
-61% -$176K
WEC icon
690
WEC Energy
WEC
$34.8B
$66K ﹤0.01%
+748
New +$71.9K
CBRL icon
691
Cracker Barrel
CBRL
$1.27B
$65K ﹤0.01%
+779
New +$107K
NEU icon
692
NewMarket
NEU
$8.49B
$65K ﹤0.01%
170
-25
-13% -$10.5K
CF icon
693
CF Industries
CF
$17.9B
$64K ﹤0.01%
2,338
-1,248
-35% -$46.4K
CLB icon
694
Core Laboratories
CLB
$572M
$64K ﹤0.01%
+6,153
New +$172K
PFF icon
695
CALL
iShares Preferred and Income Securities ETF
PFF
$13.2B
$64K ﹤0.01%
+2,000
New +$71.7K
ALL icon
696
Allstate
ALL
$66.7B
$63K ﹤0.01%
+688
New +$74.8K
MKTX icon
697
MarketAxess Holdings
MKTX
$5.72B
$63K ﹤0.01%
+190
New +$66.2K
NRG icon
698
NRG Energy
NRG
$25.3B
$63K ﹤0.01%
2,329
-6,555
-74% -$226K
AMAG
699
DELISTED
AMAG Pharmaceuticals
AMAG
$63K ﹤0.01%
+10,127
New +$89.2K
ROKU icon
700
Roku
ROKU
$22.4B
$62K ﹤0.01%
+710
New +$81.7K

Similar funds

Prelude Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.

  • Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
  • Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
  • Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
  • Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
  • Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
  • Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
  • Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.